Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Pathologic Complete Response
×
Other hematologic neoplasm
×
Clear all
Filters
3
NCT01757535
2025-07-08
QUAZAR AML-001
Celgene
Phase 3
Completed
472 enrolled
24 charts
2 FDA